INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

Eli Lilly is continuing to work to lower the out-of-pocket costs for people using insulin. The company announced that it is lowering the list price of Insulin Lispro Injection by an additional 40% ...

INDIANAPOLIS, Jan. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to add two more cost-saving options to its suite of solutions for people who use Lilly insulin by ...

A study comparing the safety and efficacy of SAR342434, a biosimilar (follow-on form) of insulin lispro-Humalog, found it to be comparable to that of the brand name drug in patients also using insulin ...

Eli Lilly & Co. said Tuesday it is reducing the list price of Insulin Lispro Injection in the U.S. by another 40% effective Jan. 1, 2022, bringing the price down to 2008 levels. "Lilly's Insulin ...

Eli Lilly & Co. said Monday it will introduce a generic version of Humalog insulin in the U.S., at a price that's half the current list price. The lower priced version, called insulin Lispro, has the ...

A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...

The cost of Humalog can vary based on several factors, including the form you use and your insurance coverage. Coupons and drug savings programs may be available to help lower the price you’ll pay for ...

A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...

We pay more than $500 every 90 days for the two insulins my Type 1 diabetic husband literally cannot live without. That’s our out-of-pocket cost. With insurance. And we’re not alone. The average ...

A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring ...